Skip to content

Opening book details…

About this Medicine article

6091 POSTER Final Results of a Multicentre Phase II Trial Assessing Sorafenib in Combination With Irinotecan as 2nd or Later-line Treatment in Metastatic Colorectal Cancer (mCRC) Patients With KRas Mutated Tumours (mt) (NEXIRI) by Samalin, E.; Bouche, O.; Thezenas, S.; Frangois, E.; Adenis, A.; Bennouna, J.; Taieb, J.; Desseigne, F.; Laurent-Puig, P.; Ychou, M. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Samalin, E.; Bouche, O.; Thezenas, S.; Frangois, E.; Adenis, A.; Bennouna, J.; Taieb, J.; Desseigne, F.; Laurent-Puig, P.; Ychou, M.
Publisher
Elsevier Science; Elsevier ; Elsevier Ltd.; Elsevier BV (ISSN 0959-8049)
Published
2011
Language
EN
Field
Medicine (Health Sciences)

More by Samalin, E.; Bouche, O.; Thezenas, S.; Frangois, E.; Adenis, A.; Bennouna, J.; Taieb, J.; Desseigne, F.; Laurent-Puig, P.; Ychou, M.

Browse all works by Samalin, E.; Bouche, O.; Thezenas, S.; Frangois, E.; Adenis, A.; Bennouna, J.; Taieb, J.; Desseigne, F.; Laurent-Puig, P.; Ychou, M.